KRAIBURG TPE at Pharmapack in Paris

KRAIBURG TPE, the manufacturer of TPR compounds, will present it’s medical solutions portfolio at Pharmapack in Paris, Booth D66. The company will showcase its THERMOLAST M compounds, which are approved for use in direct contact with blood and medications.

These materials can be colored in conformity with medical compliance requirements and open up new potential fields of applications. TPE compounds of the THERMOLAST® M portfolio can be used for medical and pharmaceutical applications such as primary medical packaging, hospital care applications and resealing membranes.

Medical and pharmaceutical products must fulfill uncompromising requirements for safety, quality and reliability. THERMOLAST® M compounds from KRAIBURG TPE have passed standard biocompatibility certifications. These portfolio materials are certified according to DIN ISO 10993-5 (cytotoxicity), -10 (intracutaneous irritation), -11 (acute system toxicity), USP Class VI (chapter 88), and DIN ISO 10993-4 (hemolysis).

Visitors attending the Pharmapack Show and visiting the KRAIBURG’s Booth D66 will have the opportunity to see and touch the referred products and applications, as well as be in touch with KRAIBURG TPE commercial and technical staff.

For more information, please visit, www.kraiburg-tpe.com/en/news_media/archives/pharmapack2018-452.